Abstract
Inflammation plays an important role in the destruction of pancreatic islet β-cells that leads to type I diabetes. This involves infiltration of T-cells and macrophages into the islets and local production of inflammatory cytokines such as interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ. Our laboratory has developed several strategies for protecting β-cells against oxidative stress and cytokine-induced cytotoxicity. These include a cytokine selection strategy that results in cell lines that are resistant to the combined effects of IL-1β+IFN-γ. More recently, we have combined the cytokine selection procedure with overexpression of the antiapoptotic gene bcl-2, resulting in cell lines with greater resistance to oxidative stress and cytokine-induced damage than achieved with either procedure alone. This article summarizes this work and the remarkably divergent mechanisms by which protection is achieved in the different model systems. We also discuss the potential relevance of insights gained from these approaches for enhancing islet cell survival and function in both major forms of diabetes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
This article is cited by
-
Protection of coenzyme Q10 against contrast-induced acute kidney injury in male diabetic rats
Diabetology & Metabolic Syndrome (2021)
-
Botanical Interventions to Improve Glucose Control and Options for Diabetes Therapy
SN Comprehensive Clinical Medicine (2021)
-
MicroRNAs in islet immunobiology and transplantation
Immunologic Research (2013)
-
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Nature Medicine (2011)
-
Development of PACAP38 Analogue with Improved Stability: Physicochemical and In Vitro/In Vivo Pharmacological Characterization
Journal of Molecular Neuroscience (2011)